CHICAGO — In a large retrospective review of real-world rates of endophthalmitis after intravitreal anti-VEGF and steroid injections, rates were low and similar to reported rates in clinical trials, according to a speaker here.
“The rates were low, similar to reported rates of clinical trials. ... The majority of patients were able to regain vision within the first 2 months following the suspected endophthalmitis,” Dilsher S. Dhoot, MD, said at the American Society of Retina Specialists annual meeting.
The study of electronic medical records from Vestrum Health Retina Database